These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

754 related articles for article (PubMed ID: 33711555)

  • 1. Selective release of gastrointestinal hormones induced by an orally active GPR39 agonist.
    Grunddal KV; Diep TA; Petersen N; Tough IR; Skov LJ; Liu L; Buijink JA; Mende F; Jin C; Jepsen SL; Sørensen LME; Achiam MP; Strandby RB; Bach A; Hartmann B; Frimurer TM; Hjorth SA; Bouvier M; Cox H; Holst B
    Mol Metab; 2021 Jul; 49():101207. PubMed ID: 33711555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal Acyl-CoA synthetase 5 (ACSL5) deficiency potentiates postprandial GLP-1 & PYY secretion, reduces food intake, and protects against diet-induced obesity.
    Griffin JD; Zhu Y; Reeves A; Buhman KK; Greenberg AS
    Mol Metab; 2024 May; 83():101918. PubMed ID: 38499083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut hormones as peripheral anti obesity targets.
    Small CJ; Bloom SR
    Curr Drug Targets CNS Neurol Disord; 2004 Oct; 3(5):379-88. PubMed ID: 15544446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-arginine promotes gut hormone release and reduces food intake in rodents.
    Alamshah A; McGavigan AK; Spreckley E; Kinsey-Jones JS; Amin A; Tough IR; O'Hara HC; Moolla A; Banks K; France R; Hyberg G; Norton M; Cheong W; Lehmann A; Bloom SR; Cox HM; Murphy KG
    Diabetes Obes Metab; 2016 May; 18(5):508-18. PubMed ID: 26863991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the Enteroendocrine System for Treatment of Obesity.
    Miedzybrodzka EL; Gribble FM; Reimann F
    Handb Exp Pharmacol; 2022; 274():487-513. PubMed ID: 35419620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of GIPR in LEPR cells impairs glucose control by GIP and GIP:GLP-1 co-agonism without affecting body weight and food intake in mice.
    Akindehin S; Liskiewicz A; Liskiewicz D; Bernecker M; Garcia-Caceres C; Drucker DJ; Finan B; Grandl G; Gutgesell R; Hofmann SM; Khalil A; Liu X; Cota P; Bakhti M; Czarnecki O; Bastidas-Ponce A; Lickert H; Kang L; Maity G; Novikoff A; Parlee S; Pathak E; Schriever SC; Sterr M; Ussar S; Zhang Q; DiMarchi R; Tschöp MH; Pfluger PT; Douros JD; Müller TD
    Mol Metab; 2024 May; 83():101915. PubMed ID: 38492844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-storage and release of insulin-like peptide-5, glucagon-like peptide-1 and peptideYY from murine and human colonic enteroendocrine cells.
    Billing LJ; Smith CA; Larraufie P; Goldspink DA; Galvin S; Kay RG; Howe JD; Walker R; Pruna M; Glass L; Pais R; Gribble FM; Reimann F
    Mol Metab; 2018 Oct; 16():65-75. PubMed ID: 30104166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diet and gastrointestinal bypass-induced weight loss: the roles of ghrelin and peptide YY.
    Chandarana K; Gelegen C; Karra E; Choudhury AI; Drew ME; Fauveau V; Viollet B; Andreelli F; Withers DJ; Batterham RL
    Diabetes; 2011 Mar; 60(3):810-8. PubMed ID: 21292870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents.
    Psichas A; Sleeth ML; Murphy KG; Brooks L; Bewick GA; Hanyaloglu AC; Ghatei MA; Bloom SR; Frost G
    Int J Obes (Lond); 2015 Mar; 39(3):424-9. PubMed ID: 25109781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut hormones and appetite regulation.
    Hong SH; Choi KM
    Curr Opin Endocrinol Diabetes Obes; 2024 Jun; 31(3):115-121. PubMed ID: 38511400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bile acids are important direct and indirect regulators of the secretion of appetite- and metabolism-regulating hormones from the gut and pancreas.
    Kuhre RE; Wewer Albrechtsen NJ; Larsen O; Jepsen SL; Balk-Møller E; Andersen DB; Deacon CF; Schoonjans K; Reimann F; Gribble FM; Albrechtsen R; Hartmann B; Rosenkilde MM; Holst JJ
    Mol Metab; 2018 May; 11():84-95. PubMed ID: 29656109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters.
    le Roux CW; Aylwin SJ; Batterham RL; Borg CM; Coyle F; Prasad V; Shurey S; Ghatei MA; Patel AG; Bloom SR
    Ann Surg; 2006 Jan; 243(1):108-14. PubMed ID: 16371744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of TOTUM-63, a fibre and polyphenol rich plant-based composition, on gut and pancreatic hormone secretion in diet-induced obese mice.
    Chavanelle V; Chanon S; Pinteur C; Loizon E; Vial G; Otero YF; Le Joubioux F; Maugard T; Peltier SL; Sirvent P; Morio B
    Nutr Metab Cardiovasc Dis; 2022 Jul; 32(7):1797-1807. PubMed ID: 35618560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EndoBarrier gastrointestinal liner. Delineation of underlying mechanisms and clinical effects.
    Rohde U
    Dan Med J; 2016 Nov; 63(11):. PubMed ID: 27808040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. l-phenylalanine modulates gut hormone release and glucose tolerance, and suppresses food intake through the calcium-sensing receptor in rodents.
    Alamshah A; Spreckley E; Norton M; Kinsey-Jones JS; Amin A; Ramgulam A; Cao Y; Johnson R; Saleh K; Akalestou E; Malik Z; Gonzalez-Abuin N; Jomard A; Amarsi R; Moolla A; Sargent PR; Gray GW; Bloom SR; Murphy KG
    Int J Obes (Lond); 2017 Nov; 41(11):1693-1701. PubMed ID: 28792489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic bile acid sensing by G protein-coupled bile acid receptor 1 (GPBAR1) promotes PYY and GLP-1 release.
    Ullmer C; Alvarez Sanchez R; Sprecher U; Raab S; Mattei P; Dehmlow H; Sewing S; Iglesias A; Beauchamp J; Conde-Knape K
    Br J Pharmacol; 2013 Jun; 169(3):671-84. PubMed ID: 23488746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Gut-Intrinsic Melanocortin Signaling Complex Augments L-Cell Secretion in Humans.
    Sun EW; Iepsen EW; Pezos N; Lumsden AL; Martin AM; Schober G; Isaacs NJ; Rayner CK; Nguyen NQ; de Fontgalland D; Rabbitt P; Hollington P; Wattchow DA; Hansen T; Holm JC; Liou AP; Jackson VM; Torekov SS; Young RL; Keating DJ
    Gastroenterology; 2021 Aug; 161(2):536-547.e2. PubMed ID: 33848536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after Roux-en-Y gastric bypass surgery.
    Svane MS; Jørgensen NB; Bojsen-Møller KN; Dirksen C; Nielsen S; Kristiansen VB; Toräng S; Wewer Albrechtsen NJ; Rehfeld JF; Hartmann B; Madsbad S; Holst JJ
    Int J Obes (Lond); 2016 Nov; 40(11):1699-1706. PubMed ID: 27434221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of glucagon-like peptide-1-(7-36) amide, peptide YY, and neurotensin secretion by neurotransmitters and gut hormones in the isolated vascularly perfused rat ileum.
    Dumoulin V; Dakka T; Plaisancie P; Chayvialle JA; Cuber JC
    Endocrinology; 1995 Nov; 136(11):5182-8. PubMed ID: 7588257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects.
    Jacobsen SH; Olesen SC; Dirksen C; Jørgensen NB; Bojsen-Møller KN; Kielgast U; Worm D; Almdal T; Naver LS; Hvolris LE; Rehfeld JF; Wulff BS; Clausen TR; Hansen DL; Holst JJ; Madsbad S
    Obes Surg; 2012 Jul; 22(7):1084-96. PubMed ID: 22359255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.